Ligand Pharmaceuticals
LGND
#4130
Rank
A$3.59 B
Marketcap
$190.20
Share price
-0.24%
Change (1 day)
67.61%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.36

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.52. In 2022 the company made an earnings per share (EPS) of -$3.17 a decrease over its 2021 EPS that were of $5.55.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.36-174.39%
2022-$3.17-157.23%
2021$5.55-2571.43%
2020-$0.22-100.46%
2019$49.07353.48%
2018$10.821025%
2017$0.96-700%
2016-$0.16-100.87%
2015$18.531859.32%
2014$0.955.36%
2013$0.908.0704505322479E+18%
2012$0.0000000000-100%
2011$0.79-194.23%
2010-$0.83548.38%
2009-$0.13-98.7%
2008-$9.91-136.52%
2007$27.13-787.8%
2006-$3.94-14.58%
2005-$4.62-21.31%
2004-$5.87-55.15%
2003-$13.0881.33%
2002-$7.212.74%
2001-$7.02-45.93%
2000-$12.99-14.56%
1999-$15.20-45.52%
1998-$27.90-3.97%
1997-$29.05132.31%
1996-$12.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$22.69 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.58-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.61 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.92 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.98 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.70 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.36 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.21 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.58 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA